ICICI Bank Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1227
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:122
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

ICICI Bank Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ICICI Bank Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes ICICI Bank Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by ICICI Bank Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on ICICI Bank Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by ICICI Bank Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for ICICI Bank Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about ICICI Bank Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 30
Corporate Venturing – Deal reports 30
PARTNERSHIP 42
Partnership – Deal reports 42
CAPITAL RAISING 48
Capital Raising – Overview 48
Capital Raising – Deal reports 49
DIVESTMENTS 57
Divestments – Overview 57
Divestments – Deal reports 58
PRIVATE EQUITY & OWNERSHIP 106
Private Equity and Ownership – Deal reports 106
APPENDIX 112
Contact Us 112
About MarketLine Financial Deals Database 112
Deal Definition and Methodology 114
About MarketLine 121

List of Tables
Table 1: ICICI Bank Limited M&A volume and value trend (2014-YTD2018)
Table 2: ICICI Bank Limited M&A activity by geography (2014-YTD2018)
Table 3: ICICI Bank Limited capital raising volume and value trend (2014-YTD2018)
Table 4: ICICI Bank Limited capital raising by deal type (2014-YTD2018)
Table 5: ICICI Bank Limited divestments volume and value trend (2014-YTD2018)
Table 6: ICICI Bank Limited divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: ICICI Bank Limited M&A volume and value trend (2014-YTD2018)
Figure 2: ICICI Bank Limited M&A activity by geography (2014-YTD2018)
Figure 3: ICICI Bank Limited capital raising volume and value trend (2014-YTD2018)
Figure 4: ICICI Bank Limited capital raising by deal type (2014-YTD2018)
Figure 5: ICICI Bank Limited divestments volume and value trend (2014-YTD2018)
Figure 6: ICICI Bank Limited divestments by geography (2014-YTD2018)

★海外企業調査レポート[ICICI Bank Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …
  • SINTX Technologies Inc (SINT)
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Collagen Solutions Plc (COS):企業の財務・戦略的SWOT分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc, is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company provides sourcing and supply of high grade collagen; provision o …
  • Falco SD Holdings Co Ltd (4671):企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Konica Minolta, Inc. (4902)-医療機器分野:企業M&A・提携分析
    Summary Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment …
  • Volkswagen Financial Services AG:企業の戦略・SWOT・財務情報
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Swisscom, Ltd.:企業の戦略・SWOT・財務情報
    Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Brookwood Partnership Ltd:企業の戦略・SWOT・財務分析
    The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report Summary The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nippon Steel & Sumikin Chemical Co Ltd:企業の戦略的SWOT分析
    Nippon Steel & Sumikin Chemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Xcel Energy Inc (XEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Sunshine Biopharma Inc (SBFM):企業の財務・戦略的SWOT分析
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Japan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Olympus Corporation:企業の戦略・SWOT・財務情報
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆